89.76
price up icon1.27%   1.13
after-market Handel nachbörslich: 89.76
loading

Finanzdaten der Gilead Sciences Inc-Aktie (GILD)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
6.02%
6,686.00
7,114.00 7,051.00 6,599.00 6,352.00
Cost Of Revenue
25.74%
1,552.00
2,090.00 1,565.00 1,442.00 1,401.00
Gross Profit
2.19%
5,134.00
5,024.00 5,486.00 5,157.00 4,951.00
Operating Expenses
177.14%
9,456.00
3,412.00 2,863.00 3,492.00 3,246.00
Interest Income/Expense
0.79%
254.00
252.00 232.00 230.00 230.00
Benefits Costs and Expenses
104.58%
11,172.00
5,461.00 4,733.00 5,011.00 5,052.00
Costs And Expenses
100.07%
11,008.00
5,502.00 4,428.00 4,934.00 4,647.00
Operating Income/Loss
368.11%
-4,322.00
1,612.00 2,623.00 1,665.00 1,705.00
Nonoperating Income/Loss
68.94%
91.00
293.00 -72.00 152.00 -174.00
Income/Loss From Continuing Operations Before Tax
371.39%
-4,486.00
1,653.00 2,318.00 1,588.00 1,300.00
Income Tax Expense/Benefit, Deferred
95.41%
-723.00
-370.00 -68.00 -221.00 -303.00
Income Tax Expense/Benefit
232.91%
-315.00
237.00 146.00 549.00 316.00
Income/Loss From Continuing Operations After Tax
394.56%
-4,171.00
1,416.00 2,172.00 1,039.00 984.00
Net Income/Loss
394.28%
-4,170.00
1,417.00 2,172.00 1,039.00 985.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
100.00%
-
-12.00 -8.00 -6.00 -26.00
Basic Average Shares
124.80K%
1,247.00
-1.00 1,248.00 1,249.00 1,248.00
Diluted Average Shares
124.80K%
1,247.00
-1.00 1,257.00 1,258.00 1,261.00
Basic Earnings Per Share
390.43%
-3.34
1.15 1.75 0.84 0.81
Diluted Earnings Per Share
395.58%
-3.34
1.13 1.73 0.83 0.80
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_general BMY
$58.23
price up icon 0.60%
drug_manufacturers_general SNY
$47.98
price up icon 0.42%
drug_manufacturers_general PFE
$25.13
price up icon 0.76%
$289.90
price up icon 0.71%
drug_manufacturers_general NVS
$103.85
price up icon 0.74%
drug_manufacturers_general MRK
$99.86
price up icon 2.48%
Kapitalisierung:     |  Volumen (24h):